flumazenil has been researched along with scopolamine hydrobromide in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (16.00) | 18.7374 |
| 1990's | 8 (32.00) | 18.2507 |
| 2000's | 6 (24.00) | 29.6817 |
| 2010's | 7 (28.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| McNamara, RK; Skelton, RW | 1 |
| Forster, MJ; Lal, H; Prather, PL | 1 |
| Ichihara, K; Kameyama, T; Nabeshima, T; Tohyama, K | 1 |
| Bilsky, EJ; Marglin, SH; Reid, LD | 1 |
| Kameyama, T; Nabeshima, T; Tohyama, K | 1 |
| Kulkarni, SK; Sharma, AC | 1 |
| Haigh, JR; Lines, CR; Poppleton, P; Preston, GC; Traub, M; Ward, C | 1 |
| Fuxe, K; Ogren, SO | 1 |
| Sansone, M | 1 |
| Kulkarni, SK; Shaji, AV | 1 |
| Bishop, KI; Curran, HV | 1 |
| Kaneko, T; Kikusui, T; Tonohiro, T | 1 |
| Cook, JM; DeLorey, TM; He, X; Lameh, J; Lin, RC; Loew, GH; McBrady, B | 1 |
| Del Río, J; Diez-Ariza, M; García-Alloza, M; Lasheras, B; Ramírez, MJ; Redondo, C | 1 |
| Akanmu, MA; Bamitale, KD; Ukponmwan, OE | 1 |
| Hashimoto, T; Hatayama, Y; Nakamichi, K; Yoshida, N | 1 |
1 review(s) available for flumazenil and scopolamine hydrobromide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for flumazenil and scopolamine hydrobromide
| Article | Year |
|---|---|
An investigation of the effects of benzodiazepine receptor ligands and of scopolamine on conceptual priming.
Topics: Adolescent; Adult; Female; Flumazenil; GABA Modulators; Humans; Lorazepam; Male; Memory; Middle Aged; Muscarinic Antagonists; Neuropsychological Tests; Scopolamine | 1998 |
23 other study(ies) available for flumazenil and scopolamine hydrobromide
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Assessment of a cholinergic contribution to chlordiazepoxide-induced deficits of place learning in the Morris water maze.
Topics: Acetylcholine; Animals; Chlordiazepoxide; Drug Interactions; Flumazenil; Learning; Male; Memory; Physostigmine; Rats; Receptors, Cholinergic; Receptors, GABA-A; Scopolamine | 1992 |
Learning and memory-enhancing effects of Ro 15-4513: a comparison with flumazenil.
Topics: Amnesia; Animals; Avoidance Learning; Azides; Benzodiazepines; Discrimination Learning; Flumazenil; Learning; Memory; Mice; Mice, Inbred ICR; Scopolamine; Stimulation, Chemical | 1992 |
Attenuation of benzodiazepine-induced passive avoidance deficit by post-training administration of muscimol: interaction with the cholinergic neuronal system.
Topics: Animals; Anti-Anxiety Agents; Avoidance Learning; Bicuculline; Chlordiazepoxide; Flumazenil; Male; Mice; Mice, Inbred Strains; Muscimol; Neurons; Parasympathetic Nervous System; Receptors, Cholinergic; Receptors, GABA-A; Scopolamine | 1990 |
Using antagonists to assess neurochemical coding of a drug's ability to establish a conditioned place preference.
Topics: Analgesics; Animals; Brain Chemistry; Conditioning, Operant; Flumazenil; Habituation, Psychophysiologic; Male; Morphine; Naloxone; Naltrexone; Rats; Rats, Inbred Strains; Scopolamine | 1990 |
Effects of DM-9384, a pyrrolidone derivative, on alcohol- and chlordiazepoxide-induced amnesia in mice.
Topics: Amnesia; Animals; Avoidance Learning; Bicuculline; Central Nervous System Agents; Chlordiazepoxide; Drug Interactions; Ethanol; Flumazenil; Male; Mice; Pyrrolidinones; Retention, Psychology; Scopolamine | 1990 |
Evidence for GABA-BZ receptor modulation in short-term memory passive avoidance task paradigm in mice.
Topics: Animals; Avoidance Learning; Carbolines; Electroshock; Female; Flumazenil; gamma-Aminobutyric Acid; Male; Memory, Short-Term; Mice; Physostigmine; Receptors, GABA-A; Scopolamine | 1990 |
Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmine.
Topics: Acoustic Stimulation; Adult; Anti-Anxiety Agents; Attention; Cognition Disorders; Dementia; Disease Models, Animal; Female; Flumazenil; Humans; Male; Memory Disorders; Photic Stimulation; Physostigmine; Psychomotor Performance; Pupil; Reaction Time; Scopolamine | 1989 |
D1- and D2-receptor antagonists induce catalepsy via different efferent striatal pathways [corrected].
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Catalepsy; Corpus Striatum; Dose-Response Relationship, Drug; Flumazenil; Injections, Intraperitoneal; Male; Muscimol; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Scopolamine | 1988 |
Scopolamine-induced locomotor stimulation in mice: effect of diazepam and a benzodiazepine antagonist.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepinones; Diazepam; Flumazenil; Male; Mice; Mice, Inbred BALB C; Motor Activity; Scopolamine | 1982 |
Evidence of GABAergic modulation in melatonin-induced short-term memory deficits and food consumption.
Topics: Animals; Antioxidants; Diazepam; Eating; Female; Flumazenil; GABA Modulators; Latency Period, Psychological; Male; Maze Learning; Melatonin; Memory Disorders; Memory, Short-Term; Mice; Muscarinic Antagonists; Rats; Rats, Wistar; Receptors, GABA; Scopolamine; Triazolam | 1998 |
The allocentric place discrimination task is selectively and highly dependent on the central muscarinic system in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Brain; Diazepam; Discrimination Learning; Dizocilpine Maleate; Flumazenil; Male; Mecamylamine; Ondansetron; Rats; Rats, Inbred F344; Receptors, Muscarinic; Scopolamine; Swimming | 2000 |
Influence of benzodiazepine binding site ligands on fear-conditioned contextual memory.
Topics: Animals; Azides; Benzodiazepines; Binding Sites; Binding, Competitive; Carbolines; Conditioning, Psychological; Convulsants; Fear; Flumazenil; GABA Antagonists; GABA Modulators; Imidazoles; Ligands; Male; Memory; Mice; Mice, Inbred C57BL; Motor Activity; N-Methylscopolamine; Piperazines; Quinolines; Receptors, GABA-A; Scopolamine; Silanes; Tritium | 2001 |
Flumazenil and tacrine increase the effectiveness of ondansetron on scopolamine-induced impairment of spatial learning in rats.
Topics: Animals; Cholinesterase Inhibitors; Drug Therapy, Combination; Flumazenil; Learning; Male; Maze Learning; Memory; Muscarinic Antagonists; Ondansetron; Rats; Rats, Wistar; Receptors, GABA-A; Scopolamine; Serotonin Antagonists; Tacrine | 2003 |
Neuropharmacological profile of aqueous extract of Anaphe venata larva (Notondotidae) in rats.
Topics: Amphetamine; Animals; Ataxia; Behavior, Animal; Dose-Response Relationship, Drug; Flumazenil; Grooming; Injections, Intraperitoneal; Larva; Locomotion; Moths; Naloxone; Neuropharmacology; Neurotransmitter Agents; Rats; Scopolamine; Stereotyped Behavior; Thiamine; Water | 2011 |
Procognitive effect of AC-3933 in aged mice, and synergistic effect of combination with donepezil in scopolamine-treated mice.
Topics: Aging; Animals; Donepezil; Drug Synergism; Flumazenil; GABA-A Receptor Agonists; Indans; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Naphthyridines; Nootropic Agents; Oxadiazoles; Piperidines; Rats; Scopolamine | 2014 |